The myelodysplastic syndromes

Oncologist

Volumn 2, Issue 1, 1997, Pages 28-39

  Cheson, Bruce D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; AZACITIDINE; AZATHIOPRINE; CARBOPLATIN; CISPLATIN DERIVATIVE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DANAZOL; DAUNORUBICIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ERYTHROPOIETIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; ISOTRETINOIN; PREDNISOLONE; PREDNISONE; RETINOIC ACID; THROMBOPOIETIN; TIOGUANINE; TOPOTECAN; UNINDEXED DRUG; VINCRISTINE; ZORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYELODYSPLASTIC SYNDROME; PRELEUKEMIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030998119     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-1-28     Document Type: Article

References (20)

1. Nand S, Godwin JE. Hypoplastic myelodysplastic syndrome. Cancer 1988;62:958-964.
2. Hamblin TJ, Oscier DG. The myelodysplastic syndrome - a practical guide. Hematol Oncol 1987;5:19-34.
3. Miller BA, Linet MS, Cheson BD. Leukemias. In: Miller BA, Gloeckler Ries LA, Hankey BF, eds. SEER Cancer Statistics Review: 1973-1990. Bethesda, MD: National Cancer Institute, 1993;XIII:1-23.
4. Bennett JM, Catovsky D, Daniel M-T et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
5. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British group. Ann Intern Med 1985;103:626-629.
6. Cheson BD, Cassileth PA, Head DR et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990;8:813-819.
7. Fenaux P, Beuscart R, Lai JL et al. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. J Clin Oncol 1988;6:1417-1424.
8. Tefferi A, Hoagland HC, Themeau TM et al. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin Proc 1989;64:1246-1254.
9. Tricot G, Vlietinck R, Boogaerts MA et al. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosome analysis. Br J Haematol 1985;60:19-32.
10. Todd WM, Pierre RV. Preleukaemia: a long-term prospective study of 326 patients. Scand J Haematol 1986;36(suppl 45):114-120.
11. Vallespí T, Torrabadella M, Julia A et al. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification. Br J Haematol 1985;61:81-92.
12. Kerkhofs H, Hermans J, Maak HL et al. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 1987;65:83-92.
13. Weisdorf DJ, Oken MM, Johnson GJ et al. Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia. Br J Haematol 1983;55:691-700.
14. Kantarjian HM, Keating MJ, Walters RS et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 1986;4:1748-1757.
15. Mufti GJ, Stevens JR, Oscier DG et al. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985;59:425-433.
16. Foucar K, Langdon RM, Armitage JO et al. Myelodysplastic syndromes. A clinical and pathologic analysis. Cancer 1985;56:553-561.
17. + cells: an adverse prognostic factor in the myelodysplastic syndromes. Am J Hematol 1992;39:96-101.
18. Sanz GF, Sanz MA, Vallespí T et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989;74:395-408.
19. Tricot G, De Wolf-Peeters C, Vlietinck R et al. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors. Br J Haematol 1984;58:217-225.
20. Varela BL, Chuang C, Woll JE et al. Modifications in the classification of primary myelodysplastic syndromes: the addition of a scoring system. Hematol Oncol 1985;3:55-63.